pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3120 |
Genomic Coordinates | chr1: 172138808 - 172138888 |
Description | Homo sapiens miR-3120 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3120-5p | |||||||||||||||||||||
Sequence | 13| CCUGUCUGUGCCUGCUGUACA |33 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||
Editing Events in miRNAs |
|
DRVs in miRNA |
|
|||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TGIF2 | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | TGFB induced factor homeobox 2 | ||||||||||||||||||||
Transcript | NM_021809 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TGIF2 | |||||||||||||||||||||
3'UTR of TGIF2 (miRNA target sites are highlighted) |
>TGIF2|NM_021809|3'UTR 1 GCATCTGCCAAGAAGGGTGCTGAAGGCTCCAGCCAGCTGTCCTGGGTTTCCGTTTTGGTTCCCTTTCATACAGAGGGTTT 81 TCTATGGATCACTGCCAAACATTGGGATCATCTCCTCTGTCCAGAGGTCTTCAACAGGAAGATGCCAGCTGGCACCACTG 161 CACTGTGATGGGGGCCCTCTCCTCTGCTGACTCTGCCGTTTCTCCAGGCCTCCGCTCAGTGATGAGACCAAGAGATCGGA 241 GACAAGCATGGTGCTGCTGCTTCTGCTGCTTCTCCAGAAAATCCCTGGGACACCTTTGTTCCAGCCTGGTTTCCTGGGCT 321 GGGCTCAGGAAAGCTGCCAAATTCAGTCCTATGTTGGGTCCAAGCTGCCCCTGTGCTGTTTCTGTCAAGCCAGGTGTGGA 401 CATTCCAAGTTCATATGCGTGAACAAAAGAAAAGAGGAACCCAGTGGATGTAACAGAACCGACTCCAGTTGAATGTTTAG 481 ATTTTTGCTAAACTGTTTTCTTTTTCCCTTTTTTGCTGTGGTTTGCATTCACGGCAGTAGTTAGCCCAGGTGTGGGGAAC 561 GAGAGTGCACTGCATGATAGCGTTCTGGTGAGCTGGGAAGGACCCACCACTGCCACTGAGGATTGTTTTGGAAGAAAGGA 641 ATATTTTTATCTTGGGGACCAGCTAAGTCTCTGCAGTAGTGTGAAATTCCAAATGGTTGTTTTATCATTGGTTTGGTTTA 721 CCAAAAAAAAGGCAGGGAAAAAAAAAAAAAACAACCGTATGAGCGCATTGGCTTGTCTGCCGCAGGCACAGAAGGGTAGA 801 AAGCCACAGCAGGGGGCAGTCCAGCAGACTCTGACTCAACTTTCTAGGCACCTAGCAGAGAAAGATAAGATCAAAAGGTG 881 TTTGGTTTTTCTTTTAATTTTTATTGTAGTTTTTTTGGGTGGGTGGGGGAAGTAAACTAGACTGAAGCGATGGATTTTTT 961 TTTTCTTTTTTTTCTTTAGTGTTTTTCCCTTTGTTCTTGAACACTTTTGCCCTGCAGCCTCAGTTTTGAATTCTTTTAGC 1041 AACTTGGATTAGAGGGGCCCATATGTCAGAAGCTCCCAGCACCTCCTACTTGGGAGAAAAGTGAGCCATCTGCTGGTCAG 1121 GAAGTCCTCCAGAGAGGCAGCTTTTCCCACAATGGTGGCAGGAAACTTTGGGGAAAGCAGGAATGGTGTCCACTGCTGCG 1201 GAGGAACTGCCTTCAGAGAAGGTGGGGCTGGAAAAGGGTTAGAAGCCTCCTAGCTGGGATTGTCTTTGTTTCACCTTTCT 1281 TTAAATTAGAATTACAGAAGCCCCTGCCCAGTGAACAGATAACGATTGGTCTTATGCTCCTCCCTTTCCCCCATTTTTTC 1361 TTTTGCTGTTTTGTTTTTTGTTTTTTGTTTGTTTGTTTGTTTTTTTGAGACAGAGTCATGCTCTGTCACCCGGGCTGGAG 1441 TGCAGTGGTGCGATCTCAGCTCACTGTAACCTCCGCCTCCCGGGTTCAAGCAATTATTTGCCTCAGCCTCCCGAGTAGCT 1521 GGGATTATAGGCACCCGCCACCATGTCTGGCTTTTAGTAGAGACGGGGTTTCACCATCTTGGCCAGGCTGGTCTTGGAAC 1601 TCCTGACCTCGTGAGCCACCACGCCCAGCCTCTTTTGCTGTTTCATTGCTGACAGTGTTCAACAATATGCCCCATCTTTA 1681 TATATCCTAAGAAACACTAATCCTAGGTTATTGCTAGCCAAAATATTTTTGTCCTGAGTAGTGTCACTGGGCCAAAAGAT 1761 AGATCAGGACGACAGCCTTTAGTTTTCCTGAAATCACCAGGTCAGGCACAAGGAGAAAAGGTTCCTGGATACTGACTAAC 1841 TTGGGTGGGTCTAGCCAGGAGAAAGACAGTAACATGTGTTCTGTACTTTCTGGGAAGATCCCTGAAGCCATCACAGAGGC 1921 TCCCCAACTTCTGAGTCGCCCATCTGTTGCTGTGGGAGTGTGAACGGATCGCTGAAGGAGAGGGAGCTTTGCTCTCTCTA 2001 GGTGGGCAAGTTTCCTGGGCTCTCTGTGTTGCCTCCCTCTGGCTTCTTCCTCCCGTGCCCTCTCCCCGTGTGCCCCAGGG 2081 GGATCAGGGATCCTCACCCTCCTGAGGCCCAGTGGGGAAGAATGAACATGGCTTCATCCAGGTTAACTGATGCTGCCATT 2161 TGCCCAGCCTCTTCCATCCCAGCCCTGTCAGTGAGCCCAGGTCTGGTGCAACTGCTGCAGGATGCCTGTAGTAGGGAACT 2241 CTGGAAGTGTATTGGGCTGAGGTGGGATTTTCCCTCCCCACAGTGCACTGAGCAATGGAGGGTGGTGAGGGAGCCATGCT 2321 GCTGAATTCTGGTTGGCATTTCCCCATTATGTAAAATGGGGTGTTGGGTAGGGCAGACTCTGCTTGGGTTTGGTTGTAAG 2401 ATAAACCTGGAGGAGAAGCACAGTTGTCCCATTGAATTATTTGAGCAAAAACTACTGTAAATAACTTTTTTGTCTTTTGT 2481 CAAATAAAATTTTTTTTTGTTTTTTTAAGCAGAAACAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | LCL-BAC |
Disease | MIMAT0019198 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1020023. RNA binding protein: AGO2. Condition:EBV B95-8-infected
... - Skalsky RL; Corcoran DL; Gottwein E; Frank et al., 2012, PLoS pathogens. |
Article |
- Skalsky RL; Corcoran DL; Gottwein E; Frank et al. - PLoS pathogens, 2012
Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus linked to a number of B cell cancers and lymphoproliferative disorders. During latent infection, EBV expresses 25 viral pre-microRNAs (miRNAs) and induces the expression of specific host miRNAs, such as miR-155 and miR-21, which potentially play a role in viral oncogenesis. To date, only a limited number of EBV miRNA targets have been identified; thus, the role of EBV miRNAs in viral pathogenesis and/or lymphomagenesis is not well defined. Here, we used photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) combined with deep sequencing and computational analysis to comprehensively examine the viral and cellular miRNA targetome in EBV strain B95-8-infected lymphoblastoid cell lines (LCLs). We identified 7,827 miRNA-interaction sites in 3,492 cellular 3'UTRs. 531 of these sites contained seed matches to viral miRNAs. 24 PAR-CLIP-identified miRNA:3'UTR interactions were confirmed by reporter assays. Our results reveal that EBV miRNAs predominantly target cellular transcripts during latent infection, thereby manipulating the host environment. Furthermore, targets of EBV miRNAs are involved in multiple cellular processes that are directly relevant to viral infection, including innate immunity, cell survival, and cell proliferation. Finally, we present evidence that myc-regulated host miRNAs from the miR-17/92 cluster can regulate latent viral gene expression. This comprehensive survey of the miRNA targetome in EBV-infected B cells represents a key step towards defining the functions of EBV-encoded miRNAs, and potentially, identifying novel therapeutic targets for EBV-associated malignancies.
LinkOut: [PMID: 22291592]
|
CLIP-seq Support 1 for dataset GSM4903829 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Human neurons / CTLTD_shCTL_a |
Location of target site | NM_001199514 | 3UTR | UGUUUGUUUGUUUUUUUGAGACAGAGUCAUGCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161238 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903830 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Human neurons / CTLTD_shCTL_b |
Location of target site | NM_021809 | 3UTR | GUUUGUUUGUUUUUUUGAGACAGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161238 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903831 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Human neurons / 124TD_shELAVL3_a |
Location of target site | NM_021809 | 3UTR | GUUUGUUUGUUUUUUUGAGACAGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161238 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_021809 | 3UTR | UUGUUUGUUUGUUUUUUUGAGACAGAGUCAUGCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_021809 | 3UTR | UUUGUUUGUUUGUUUGUUUUUUUGAGACAGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_021809 | 3UTR | UUUGUUUGUUUGUUUUUUUGAGACAGAGUCAUGCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_021809 | 3UTR | UGUUUGUUUGUUUGUUUUUUUGAGACAGAGUCAUGCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_021809 | 3UTR | GUUUGUUUUUUUGAGACA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 9 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_021809 | 3UTR | UUGUUUGUUUGUUUUUUUGAGACAGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 10 for dataset GSM1020023 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | LCL-BAC / EBV B95-8-infected, 4-thiouridine, RNase T1 |
Location of target site | ENST00000373874.2 | 3UTR | UUGGCUUGUCUGCCG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22291592 / GSE41437 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
134 hsa-miR-3120-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT096972 | BDP1 | B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB | 2 | 2 | ||||||||
MIRT442624 | LOX | lysyl oxidase | 2 | 2 | ||||||||
MIRT473438 | MDM4 | MDM4, p53 regulator | 2 | 2 | ||||||||
MIRT490011 | KIFC2 | kinesin family member C2 | 2 | 2 | ||||||||
MIRT496449 | N6AMT1 | N-6 adenine-specific DNA methyltransferase 1 | 2 | 2 | ||||||||
MIRT496752 | TGIF2 | TGFB induced factor homeobox 2 | 2 | 2 | ||||||||
MIRT497721 | CYP1A1 | cytochrome P450 family 1 subfamily A member 1 | 2 | 2 | ||||||||
MIRT498287 | PADI3 | peptidyl arginine deiminase 3 | 2 | 2 | ||||||||
MIRT503195 | ACVR1B | activin A receptor type 1B | 2 | 4 | ||||||||
MIRT504760 | TEP1 | telomerase associated protein 1 | 2 | 4 | ||||||||
MIRT517810 | UGDH | UDP-glucose 6-dehydrogenase | 2 | 6 | ||||||||
MIRT519686 | ZNF622 | zinc finger protein 622 | 2 | 4 | ||||||||
MIRT520263 | URGCP | upregulator of cell proliferation | 2 | 2 | ||||||||
MIRT523051 | ICMT | isoprenylcysteine carboxyl methyltransferase | 2 | 2 | ||||||||
MIRT525601 | OLR1 | oxidized low density lipoprotein receptor 1 | 2 | 4 | ||||||||
MIRT526995 | ARL8B | ADP ribosylation factor like GTPase 8B | 2 | 2 | ||||||||
MIRT528699 | TRAF3IP2 | TRAF3 interacting protein 2 | 2 | 4 | ||||||||
MIRT533142 | WNT10A | Wnt family member 10A | 2 | 2 | ||||||||
MIRT537618 | ERI1 | exoribonuclease 1 | 2 | 2 | ||||||||
MIRT539707 | EIF3H | eukaryotic translation initiation factor 3 subunit H | 2 | 2 | ||||||||
MIRT539752 | CNBP | CCHC-type zinc finger nucleic acid binding protein | 2 | 2 | ||||||||
MIRT539808 | GAPVD1 | GTPase activating protein and VPS9 domains 1 | 2 | 2 | ||||||||
MIRT539941 | IFNAR2 | interferon alpha and beta receptor subunit 2 | 2 | 2 | ||||||||
MIRT540424 | FAM83F | family with sequence similarity 83 member F | 2 | 2 | ||||||||
MIRT540509 | CXCL10 | C-X-C motif chemokine ligand 10 | 2 | 2 | ||||||||
MIRT540720 | GUF1 | GUF1 homolog, GTPase | 2 | 2 | ||||||||
MIRT541630 | PARP2 | poly(ADP-ribose) polymerase 2 | 2 | 2 | ||||||||
MIRT542286 | POLR3K | RNA polymerase III subunit K | 2 | 2 | ||||||||
MIRT542456 | AKR7A2 | aldo-keto reductase family 7 member A2 | 2 | 2 | ||||||||
MIRT542550 | MRPS10 | mitochondrial ribosomal protein S10 | 2 | 2 | ||||||||
MIRT542771 | PPAP2B | phospholipid phosphatase 3 | 2 | 2 | ||||||||
MIRT550085 | TRAPPC2 | trafficking protein particle complex 2 | 2 | 2 | ||||||||
MIRT551458 | CARKD | NAD(P)HX dehydratase | 2 | 2 | ||||||||
MIRT555622 | PHLPP2 | PH domain and leucine rich repeat protein phosphatase 2 | 2 | 2 | ||||||||
MIRT569136 | KATNAL1 | katanin catalytic subunit A1 like 1 | 2 | 2 | ||||||||
MIRT572328 | HSPB6 | heat shock protein family B (small) member 6 | 2 | 2 | ||||||||
MIRT574607 | LZIC | leucine zipper and CTNNBIP1 domain containing | 2 | 2 | ||||||||
MIRT575583 | Mcm8 | minichromosome maintenance 8 homologous recombination repair factor | 2 | 4 | ||||||||
MIRT576125 | Hrk | harakiri, BCL2 interacting protein (contains only BH3 domain) | 2 | 5 | ||||||||
MIRT576657 | Fam216a | family with sequence similarity 216, member A | 2 | 2 | ||||||||
MIRT607222 | ACSM2A | acyl-CoA synthetase medium chain family member 2A | 2 | 4 | ||||||||
MIRT607292 | CD300E | CD300e molecule | 2 | 6 | ||||||||
MIRT607746 | ANGPT4 | angiopoietin 4 | 2 | 2 | ||||||||
MIRT607905 | SPRYD4 | SPRY domain containing 4 | 2 | 2 | ||||||||
MIRT608159 | HRK | harakiri, BCL2 interacting protein | 2 | 7 | ||||||||
MIRT608657 | ABCF3 | ATP binding cassette subfamily F member 3 | 2 | 4 | ||||||||
MIRT609115 | ZNF703 | zinc finger protein 703 | 2 | 6 | ||||||||
MIRT610231 | ACOT9 | acyl-CoA thioesterase 9 | 2 | 2 | ||||||||
MIRT610870 | NUDCD3 | NudC domain containing 3 | 2 | 2 | ||||||||
MIRT611217 | MC2R | melanocortin 2 receptor | 2 | 2 | ||||||||
MIRT614858 | PLEKHA6 | pleckstrin homology domain containing A6 | 2 | 2 | ||||||||
MIRT616966 | LMX1A | LIM homeobox transcription factor 1 alpha | 2 | 2 | ||||||||
MIRT617258 | GLIPR1L2 | GLI pathogenesis related 1 like 2 | 2 | 2 | ||||||||
MIRT618009 | SLC9A3R2 | SLC9A3 regulator 2 | 2 | 2 | ||||||||
MIRT619067 | BSND | barttin CLCNK type accessory beta subunit | 2 | 4 | ||||||||
MIRT619295 | FAM26E | calcium homeostasis modulator family member 5 | 2 | 2 | ||||||||
MIRT619348 | GINM1 | glycoprotein integral membrane 1 | 2 | 2 | ||||||||
MIRT619362 | CFHR5 | complement factor H related 5 | 2 | 2 | ||||||||
MIRT619541 | PIWIL2 | piwi like RNA-mediated gene silencing 2 | 2 | 2 | ||||||||
MIRT619782 | NRIP2 | nuclear receptor interacting protein 2 | 2 | 2 | ||||||||
MIRT619994 | NPAP1 | nuclear pore associated protein 1 | 2 | 2 | ||||||||
MIRT621030 | CDC14B | cell division cycle 14B | 2 | 2 | ||||||||
MIRT622033 | STAT5A | signal transducer and activator of transcription 5A | 2 | 2 | ||||||||
MIRT622728 | PITPNM3 | PITPNM family member 3 | 2 | 2 | ||||||||
MIRT623144 | NAV2 | neuron navigator 2 | 2 | 2 | ||||||||
MIRT623600 | IPO9 | importin 9 | 2 | 2 | ||||||||
MIRT624608 | B3GALT5 | beta-1,3-galactosyltransferase 5 | 2 | 2 | ||||||||
MIRT624905 | CTCFL | CCCTC-binding factor like | 2 | 2 | ||||||||
MIRT625030 | SPC24 | SPC24, NDC80 kinetochore complex component | 2 | 2 | ||||||||
MIRT625688 | MCM8 | minichromosome maintenance 8 homologous recombination repair factor | 2 | 5 | ||||||||
MIRT626531 | EMCN | endomucin | 2 | 2 | ||||||||
MIRT627204 | ZDHHC20 | zinc finger DHHC-type containing 20 | 2 | 2 | ||||||||
MIRT628033 | LSAMP | limbic system-associated membrane protein | 2 | 2 | ||||||||
MIRT628203 | FREM2 | FRAS1 related extracellular matrix protein 2 | 2 | 2 | ||||||||
MIRT631012 | LINS | lines homolog 1 | 2 | 2 | ||||||||
MIRT633195 | HSPE1-MOB4 | HSPE1-MOB4 readthrough | 2 | 2 | ||||||||
MIRT633890 | CACNG8 | calcium voltage-gated channel auxiliary subunit gamma 8 | 2 | 2 | ||||||||
MIRT634023 | MOB4 | MOB family member 4, phocein | 2 | 2 | ||||||||
MIRT634416 | PLCXD3 | phosphatidylinositol specific phospholipase C X domain containing 3 | 2 | 2 | ||||||||
MIRT636866 | ARSE | arylsulfatase E (chondrodysplasia punctata 1) | 2 | 2 | ||||||||
MIRT642527 | ANKRD9 | ankyrin repeat domain 9 | 2 | 2 | ||||||||
MIRT645408 | FAM110A | family with sequence similarity 110 member A | 2 | 2 | ||||||||
MIRT645635 | SYTL4 | synaptotagmin like 4 | 2 | 2 | ||||||||
MIRT646013 | TNFAIP8L2 | TNF alpha induced protein 8 like 2 | 2 | 2 | ||||||||
MIRT646686 | ASGR2 | asialoglycoprotein receptor 2 | 2 | 2 | ||||||||
MIRT652838 | TACO1 | translational activator of cytochrome c oxidase I | 2 | 2 | ||||||||
MIRT655156 | PHF21B | PHD finger protein 21B | 2 | 2 | ||||||||
MIRT658491 | EXOC7 | exocyst complex component 7 | 2 | 2 | ||||||||
MIRT659398 | CORO2A | coronin 2A | 2 | 2 | ||||||||
MIRT666825 | PRCP | prolylcarboxypeptidase | 2 | 2 | ||||||||
MIRT666866 | POU2F2 | POU class 2 homeobox 2 | 2 | 2 | ||||||||
MIRT668224 | GABRA1 | gamma-aminobutyric acid type A receptor alpha1 subunit | 2 | 2 | ||||||||
MIRT673288 | PDE3A | phosphodiesterase 3A | 2 | 2 | ||||||||
MIRT673878 | KLF2 | Kruppel like factor 2 | 2 | 2 | ||||||||
MIRT681721 | KCNE4 | potassium voltage-gated channel subfamily E regulatory subunit 4 | 2 | 2 | ||||||||
MIRT682406 | PARD6B | par-6 family cell polarity regulator beta | 2 | 2 | ||||||||
MIRT684109 | MCM10 | minichromosome maintenance 10 replication initiation factor | 2 | 2 | ||||||||
MIRT684423 | TUFT1 | tuftelin 1 | 2 | 2 | ||||||||
MIRT684684 | OR7D2 | olfactory receptor family 7 subfamily D member 2 | 2 | 2 | ||||||||
MIRT686638 | TMEM184C | transmembrane protein 184C | 2 | 2 | ||||||||
MIRT689457 | NXN | nucleoredoxin | 2 | 2 | ||||||||
MIRT689627 | NAA30 | N(alpha)-acetyltransferase 30, NatC catalytic subunit | 2 | 2 | ||||||||
MIRT690773 | PLA2G2C | phospholipase A2 group IIC | 2 | 2 | ||||||||
MIRT690822 | SGSM2 | small G protein signaling modulator 2 | 2 | 2 | ||||||||
MIRT693669 | MXRA7 | matrix remodeling associated 7 | 2 | 2 | ||||||||
MIRT695553 | CLPB | ClpB homolog, mitochondrial AAA ATPase chaperonin | 2 | 2 | ||||||||
MIRT695872 | C19orf52 | translocase of inner mitochondrial membrane 29 | 2 | 2 | ||||||||
MIRT698160 | TNFRSF13C | TNF receptor superfamily member 13C | 2 | 2 | ||||||||
MIRT699933 | RUFY2 | RUN and FYVE domain containing 2 | 2 | 2 | ||||||||
MIRT708639 | UBE2W | ubiquitin conjugating enzyme E2 W | 2 | 2 | ||||||||
MIRT710816 | RAB11FIP4 | RAB11 family interacting protein 4 | 2 | 2 | ||||||||
MIRT711242 | TRAT1 | T-cell receptor associated transmembrane adaptor 1 | 2 | 2 | ||||||||
MIRT711542 | MSH3 | mutS homolog 3 | 2 | 2 | ||||||||
MIRT711749 | DTX1 | deltex E3 ubiquitin ligase 1 | 2 | 2 | ||||||||
MIRT712303 | PGM2L1 | phosphoglucomutase 2 like 1 | 2 | 2 | ||||||||
MIRT712922 | RPF2 | ribosome production factor 2 homolog | 2 | 2 | ||||||||
MIRT714027 | SYDE2 | synapse defective Rho GTPase homolog 2 | 2 | 2 | ||||||||
MIRT714768 | TERF1 | telomeric repeat binding factor 1 | 2 | 2 | ||||||||
MIRT714844 | ADAMTS17 | ADAM metallopeptidase with thrombospondin type 1 motif 17 | 2 | 2 | ||||||||
MIRT715223 | NPVF | neuropeptide VF precursor | 2 | 2 | ||||||||
MIRT716110 | GMPS | guanine monophosphate synthase | 2 | 2 | ||||||||
MIRT716174 | FAM71F2 | family with sequence similarity 71 member F2 | 2 | 2 | ||||||||
MIRT716383 | C6orf223 | chromosome 6 open reading frame 223 | 2 | 2 | ||||||||
MIRT716527 | KSR2 | kinase suppressor of ras 2 | 2 | 2 | ||||||||
MIRT716962 | P2RY6 | pyrimidinergic receptor P2Y6 | 2 | 2 | ||||||||
MIRT717605 | DSTYK | dual serine/threonine and tyrosine protein kinase | 2 | 2 | ||||||||
MIRT717696 | PTGS1 | prostaglandin-endoperoxide synthase 1 | 2 | 2 | ||||||||
MIRT721360 | ENTHD1 | ENTH domain containing 1 | 2 | 2 | ||||||||
MIRT721381 | MACC1 | MACC1, MET transcriptional regulator | 2 | 2 | ||||||||
MIRT721935 | RASSF2 | Ras association domain family member 2 | 2 | 2 | ||||||||
MIRT722094 | SUSD1 | sushi domain containing 1 | 2 | 2 | ||||||||
MIRT722837 | C17orf102 | chromosome 17 open reading frame 102 | 2 | 2 | ||||||||
MIRT722990 | TOR1A | torsin family 1 member A | 2 | 2 | ||||||||
MIRT724174 | ABCF2 | ATP binding cassette subfamily F member 2 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|